Nasdaq ubx.

SOUTH SAN FRANCISCO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...Find the latest Institutional Holdings data for Unity Biotechnology, Inc. Common Stock (UBX) at Nasdaq.com. Nov 10, 2021 · Third Quarter Financial Results. Cash, cash equivalents, and marketable securities totaled $88.5 million as of September 30, 2021 compared with $115.6 million as of December 31, 2020. UNITY ... SAN FRANCISCO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today ...

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...Follow. SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or ...Oct 17, 2023 · Unity Biotechnology (NASDAQ: UBX) primarily focuses on developing therapeutics targeting age-related ophthalmologic and neurologic diseases. Its main candidate, UBX1325, is being studied for ...

Mar 15, 2022 · SOUTH SAN FRANCISCO, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...

SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...– Topline 12-week results for Phase 2 study of UBX0101 in osteoarthritis expected in 3Q 2020 – – First-in-human study for UBX1325 in age-related eye disease expected to commence in 2H 2020 –Their UBX share price targets range from $4.00 to $10.00. On average, they anticipate the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 226.6% from the stock's current price. View analysts price targets for UBX or view top-rated stocks among Wall Street analysts.Unity Biotechnology, Inc. (NASDAQ:UBX) was in 4 hedge funds' portfolios at the end of September. UBX shareholders have witnessed a decrease in hedge fund interest recently.

Unity Biotechnology Inc (NASDAQ: UBX) has received an upgrade from Wedbush analyst Andreas Argyrides. The shares were upgraded from Neutral to Outperform, with the price target raised from $2 to $4. This upgrade is based on the company’s strong cash position, which is expected to support its various initiatives, including the upcoming Ph2b ...

Dec 1, 2023 · Unity Biotechnology (UBX) Insider Trading Activity 2023. MarketBeat Week in Review – 11/27 - 12/1. Teen girls are being victimized by deepfake nudes. One family is pushing for more protections. S&P 500 4,594.63. DOW 36,245.50.

Cash used in operations during the first and second quarters of 2022 was $29.8 million compared to $28.5 million for the first and second quarters of 2021. Research and development expenses ...NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 1.9400 -0.0300 (-1.52%) At close: 04:00PM EST 1.9600 +0.02 (+1.03%) After hours: 07:11PM …Nov 20, 2023 · About the Company. Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company’s lead drug candidate includes UBX1325, which is phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema ... Get the latest Unity Biotechnology, Inc. (UBX) stock news and headlines to help you in your trading and investing decisions.Follow. SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) (Nasdaq:UBX), a biotechnology company developing therapeutics to ...SOUTH SAN FRANCISCO, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing ...Dec 1, 2023 · Unity Biotechnology (UBX) Insider Trading Activity 2023. MarketBeat Week in Review – 11/27 - 12/1. Teen girls are being victimized by deepfake nudes. One family is pushing for more protections. S&P 500 4,594.63. DOW 36,245.50.

The average one-year price target for Unity Biotechnology (NASDAQ:UBX) has been revised to 6.63 / share. This is an increase of 8.33% from the prior estimate of 6.12 dated October 31, 2023. May 1, 2021 · SOUTH SAN FRANCISCO, Calif., May 01, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ... SAN FRANCISCO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...Unity Biotechnology, Inc. Common Stock (UBX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.UBX:NSQNASDAQ; Germany; 9U90:BERBerlin Stock Exchange · 9U90:DEUGerman Composite ... UBX:NSQ price falls below 50-day moving average to 2.03 at 12:17 GMT 12 ...Unity Biotechnology, Inc. Common Stock (UBX) Stock Price, Quote, News & History | Nasdaq. when trading, helping you to optimize your price and have a successful order execution. Nasdaq Data...

Markets Home UBX • NASDAQ Unity Biotechnology Inc Follow Share $1.92 After Hours: $1.91 (0.52%) -0.0100 Closed: Dec 1, 7:36:27 PM GMT-5 · USD · NASDAQ · Disclaimer …UNITY to host investor call today, March 27, at 8:00 a.m. ET. SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology ...

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow ... Jan 10, 2023 · Last November, Wedbush analyst Andreas Argyrides raised his price target on Unity Biotechnology, Inc. (NASDAQ:UBX) to $36 from $4 and maintained an Outperform rating on the shares. Unity Biotechnology (NASDAQ: UBX) primarily focuses on developing therapeutics targeting age-related ophthalmologic and neurologic diseases. Its main candidate, UBX1325, is being studied for ...SOUTH SAN FRANCISCO, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...SOUTH SAN FRANCISCO, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of ...Unity Biotechnology, Inc. (NASDAQ:UBX) was in 4 hedge funds' portfolios at the end of September. UBX shareholders have witnessed a decrease in hedge fund interest recently.

SAN FRANCISCO, July 30, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...

Wedbush says the company ended q3 with cash and equivalents of $45.9m. The investment firm raised its price target to $4 from $2, citing the company's lead drug candidate. Xwel, ubx and bwen are among pre market gainers. Wavedancer (wavd) +108% announces merger agreement with firefly neuroscience.

View the latest Unity Biotechnology Inc. (UBX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Average portfolio weight of all funds dedicated to UBX is 0.43%, an increase of 121.18%. Total shares owned by institutions decreased in the last three months by 91.02% to 4,503K shares.SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SAN FRANCISCO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...SOUTH SAN FRANCISCO, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Unity Biotechnology, Inc. (NASDAQ: UBX) was in 4 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic is 7. UBX shareholders have witnessed a ...Apr 25, 2023 · Unity Biotechnology (NASDAQ:UBX) has observed the following analyst ratings within the last quarter: These 8 analysts have an average price target of $10.5 versus the current price of Unity ... UNITY Biotechnology stock quote and UBX charts. Latest stock price today and the US's most active stock market forums.The average price point forecasted by analysts for Unity Biotechnology Inc (UBX) is $7.33, which is $5.41 above the current market price. The public float for UBX is 13.19M, and currently, short sellers hold a 4.92% ratio of that floaft. The average trading volume of UBX on November 28, 2023 was 56.51K shares. Top 5 EV Tech Stocks to Buy for 2023.Nov 18, 2023 · HC Wainwright restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. HC Wainwright also issued estimates for Unity Biotechnology’s Q4 2023 earnings at ($1.15) EPS, FY2024 earnings at ($3.83) EPS, FY2025 […]

Find real-time UBX - UNITY Biotechnology Inc stock quotes, company profile, news and forecasts from CNN Business.ROTH CAPITAL PA WEDBUSH SECURIT Analyst Back to UBX Overview Analyst price targets provided by TipRanks. About Analyst Research Nasdaq Analyst Research …Mar 15, 2022 · SOUTH SAN FRANCISCO, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ... Unity Biotechnology (NASDAQ: UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325. UBX1325 is a treatment in development that Unity is ...Instagram:https://instagram. blaine magiciangood gold mining stockstarget doordashnew jersey mortgage lenders 52-week range: $0.42 – $3.64 Unity Biotechnology (NASDAQ:UBX) focuses primarily on the development of therapeutics that target age-related ophthalmologic and neurologic diseases.. Its central ... best insurance for moving companiesunder 10 stocks – Topline 12- and 24-week results expected in 2H 2020 – SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing ...27 thg 3, 2023 ... Unity Biotechnology (NASDAQ:UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325. top 5 chase credit cards Wedbush upgraded shares of Unity Biotechnology (NASDAQ:UBX – Free Report) from a neutral rating to an outperform rating in a report published on Thursday, Marketbeat reports. They currently have $4.00 price objective on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Unity ...Find the latest Institutional Holdings data for Unity Biotechnology, Inc. Common Stock (UBX) at Nasdaq.com.